目次

RM1: Describing Research Results 

RM1-Step1: Describing methods     

RM1-Step1a（Procedure）

a total of * patients were	ex. a total of * patients were enrolled
were randomly assigned to	ex. a total of * patients were randomly assigned to receive
	ex. participants were randomly assigned to one of
were available for	ex. data were available for * patients
the median duration	ex. the median duration of follow-up was * months
the most common	ex. the most common reason for discontinuation

 

RM1-Step2: Indicating specific observations

RM1-Step2a（Presentation of results）

Table 1 shows	ex. Table 1 shows the characteristics of
shown in	ex. are shown in Table 1
presented in	ex. are presented in Table 1
the baseline characteristics of	the baseline characteristics of the patients	ex. Table 1 shows the baseline characteristics of

 

RM1-Step2b（Findings）

we found	ex. we found that
we noted	ex. we noted a significant
were observed in	ex. responses were observed in
were found
were detected
patients had
survival was * months	ex. median progression-free survival was * months

 

RM1-Step2c（Possibility）

were more likely to	were more likely to have
	were more likely to be
were less likely to

 

RM1-Step3: Indicating comparison or changes

RM1-Step3a（Comparison）

was associated with	ex. was associated with a lower risk of
significantly associated with
there was a significant	ex. there was a significant difference
	ex. there was a significant interaction between
was significantly	was significantly higher
	was significantly lower
was higher in
was highest
group than in the	ex. higher in the * group than in the
after adjustment for
compared with	as compared with	as compared with patients

RM1-Step3b（Changes）

increase in	ex. associated with a significant increase in
increased significantly	ex. increased significantly in the cohort
significantly increased	ex. had a significantly increased risk
	ex. was/were significantly increased
increased by
decreased by
increased from * to
decreased from * to
increased in
accounted for

 

RM1-Step3c（Similarity）

was/were similar	was/were similar in	were similar in the two groups
		characteristics were similar in
	was/were similar between	was similar between groups
	was/were similar to	were similar to those
were well balanced	ex. were well balanced between
baseline characteristics were	ex. baseline characteristics were similar between
	ex. baseline characteristics were well balanced between
were consistent with

 

RM1-Step3d（No difference）

did not differ	did not differ significantly	did not differ significantly between
	did not differ between
was not significant	ex. difference was not significant
there was no	there was no significant difference
	there was no evidence
there were no	there were no significant differences
did not change	ex. did not change substantially

 

RM2: Describing Adverse Events

RM2-Step1: Describing adverse events

RM2-Step1a（Adverse events）

the most common adverse events	ex. the most common adverse events were fatigue
the incidence of adverse events	ex. the incidence of adverse events was similar in the two groups
rate of serious adverse events
serious adverse events occurred in * patients
adverse events were reported in * patients
had a serious adverse event	ex. patients had a serious adverse event
one or more serious adverse	ex. participants had one or more serious adverse event
adverse events related to
are summarized in	ex. adverse events are summarized in Table 1
limit of the normal range	ex. times the upper limit of the normal range

 

RM2-Step1b（No adverse events）

no serious adverse events	ex. no serious adverse events were reported
did not differ significantly between	ex. rate of serious adverse events did not differ significantly between
there were no	there were no significant differences
we noted no	ex. we noted no significant difference between

 

RM2-Step2: Indicating discontinuation

RM2-Step2a（Discontinuation）

discontinuation of the study drug	ex. led to discontinuation of the study drug
discontinued the study drug	ex. patient discontinued the study drug